Arcus Biosciences
Price & Volume
Stats
See more52W Range | $8.84-$31.73 |
Market Cap | $3.6B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $236M |
Revenue Growth (YoY) | -39.3% |
Gross Profit (12 Mos) | -$287M |
Diluted EPS | -$3.17 |
News
See moreYahoo Finance • 2 months ago
How Eisai (TSE:4523) Is Reframing Its Story With A Tweaked Fair Value Outlook
Yahoo Finance • 2 months ago
Damora Therapeutics (DMRA) Appoints Jennifer Jarrett as President, Chief Executive Officer
Yahoo Finance • 3 months ago
Gilead’s Arcus Pullback and Idvynso HIV Challenge Might Change The Case For Investing In GILD
Yahoo Finance • 3 months ago
5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up
About
CEO | Dr. Terry J. Rosen Ph.D. |
CFO | Mr. Robert C. Goeltz II |
Address | 3928 Point Eden Way, Hayward, CA, United States, 94545 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 601 |